These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6354438)

  • 21. Transcriptional regulation of aldo-keto reductase 1C1 in HT29 human colon cancer cells resistant to methotrexate: role in the cell cycle and apoptosis.
    Selga E; Noé V; Ciudad CJ
    Biochem Pharmacol; 2008 Jan; 75(2):414-26. PubMed ID: 17945194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    Vinh DB; McIvor RS
    J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated bycounterflow elutriation.
    James R; May C; Diers M; Wagner J; McIvor R
    Bone Marrow Transplant; 1999 Oct; 24(8):815-21. PubMed ID: 10516690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-resistant dihydrofolate reductases: generation, expression and therapeutic application.
    McIvor RS
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S50-4. PubMed ID: 8971409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid emergence of methotrexate resistance in cultured mouse cells.
    Rath H; Tlsty T; Schimke RT
    Cancer Res; 1984 Aug; 44(8):3303-6. PubMed ID: 6744265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
    Chen G; Wright JE; Rosowsky A
    Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [p53 with a mutation in codon 273 increases the probability of amplifying the dhfr gene in Rat-1 and LIM1215 cells].
    Il'inskaia GV; Pugacheva EN; Sokova OI; Chumakov PM; Kopnin BP
    Genetika; 1995 May; 31(5):611-6. PubMed ID: 7622024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene amplification in drug resistance: of mice and men.
    Curt GA; Cowan KH; Chabner BA
    J Clin Oncol; 1984 Jan; 2(1):62-4. PubMed ID: 6699659
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Key determinants in the occurrence of clonal variation in humanized antibody expression of cho cells during dihydrofolate reductase mediated gene amplification.
    Kim NS; Byun TH; Lee GM
    Biotechnol Prog; 2001; 17(1):69-75. PubMed ID: 11170482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rates of development of methotrexate resistance in heterogeneous mouse mammary tumor cell cultures.
    Miller BE; Matherly LH; Lehotan M; Heppner GH
    J Exp Ther Oncol; 1996 Jan; 1(1):30-8. PubMed ID: 9414386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells.
    Domin BA; Grill SP; Bastow KF; Cheng YC
    Mol Pharmacol; 1982 Mar; 21(2):478-82. PubMed ID: 7099148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of methotrexate resistance in osteosarcoma.
    Guo W; Healey JH; Meyers PA; Ladanyi M; Huvos AG; Bertino JR; Gorlick R
    Clin Cancer Res; 1999 Mar; 5(3):621-7. PubMed ID: 10100715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired versus intrinsic resistance to methotrexate: diversity of the drug-resistant phenotype in mammalian cells.
    Melera PW
    Semin Cancer Biol; 1991 Aug; 2(4):245-55. PubMed ID: 1912529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to methotrexate due to gene amplification in a patient with acute leukemia.
    Carman MD; Schornagel JH; Rivest RS; Srimatkandada S; Portlock CS; Duffy T; Bertino JR
    J Clin Oncol; 1984 Jan; 2(1):16-20. PubMed ID: 6583326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate resistance and gene amplification. Mechanisms and implications.
    Schimke RT
    Cancer; 1986 May; 57(10):1912-7. PubMed ID: 3513938
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acquisition of resistance to anticancer agents by overproduction of target enzymes].
    Inaba M
    Nihon Rinsho; 1997 May; 55(5):1030-7. PubMed ID: 9155148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate resistant cells as targets for selective chemotherapy.
    Bertino JR; Mini E; Sobrero A; Moroson BA; Love T; Jastreboff M; Carmen M; Srimatkandada S; Dube S
    Adv Enzyme Regul; 1985; 24():3-11. PubMed ID: 3915186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fifth Gordon Hamilton-Fairley memorial lecture. Methotrexate resistance and gene amplification: an experimental model for the generation of cellular heterogeneity.
    Schimke RT; Hill A; Johnston RN
    Br J Cancer; 1985 Apr; 51(4):459-65. PubMed ID: 3978027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA amplification and multidrug resistance.
    Borst P
    Nature; 1984 Jun 14-20; 309(5969):580. PubMed ID: 6728017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.